10times
19 - 21 Jan 2021Ended

Cannabinoid Derived Pharmaceuticals Industry Review Summit

AboutSpeakersExhibitorsReviewsPhotos

Estimated Turnout

upto 100
Delegates
Based on previous editions

Editions

Jan 2021

Frequency

Not Available
Claim event to edit details

Cannabinoid derived pharmaceuticals have faced many challenges in their development. Cannabis prohibition being the original and biggest obstruction .. Read more to progress. Now the industry has started facing new, more acute challenges like finding suitable patient populations and designing robust trials, working with regulators around the world with varying attitudes towards cannabis, selecting the most pharmacologically appropriate synthetic or phytocannabinoid possible just to name a few. Along with the challenges COVID-19 has created over the past months many of these other challenges have been facing the industry for years. finding suitable patient populations and designing robust trials, working with regulators around the world with varying attitudes towards cannabis, selecting the most pharmacologically appropriate synthetic or phytocannabinoid possible. Introducing the first Cannabinoid Derived Pharmaceuticals Industry Review Summit, taking place virtually 19th – 21st January. Attending online will give you access to the same opportunities as a physical attendee through our purpose-built online conference platform.

  • Share your Experience
  • Organizer
Logo Follow Company

Hanson Wade Limited

UK355 Total Events / 51 Upcoming Events95+ Followers

More Events From The Organizer